TS
Therapeutic Areas
U-Ploid Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Lead Egg Quality Therapeutic | Improvement of egg quality / reduction of meiotic aneuploidy in women aged 33+ undergoing IVF | Pre-clinical |
| Drug | Indication | Phase |
|---|---|---|
| Lead Egg Quality Therapeutic | Improvement of egg quality / reduction of meiotic aneuploidy in women aged 33+ undergoing IVF | Pre-clinical |